CEL-SCI CORPORATION Lessee, Operating Lease, Liability, to be Paid, Year One
CEL-SCI CORPORATION (CVM) had Lessee, Operating Lease, Liability, to be Paid, Year One of $357.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Commitment and Contingencies › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths · last filed 2026-08-14
- 2026-06-30: Lessee, Operating Lease, Liability, to be Paid, Year One $357.00K.
- 2026-03-31: Lessee, Operating Lease, Liability, to be Paid, Year One $357.00K.
- 2025-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $357.00K.
- 2025-09-30: Lessee, Operating Lease, Liability, to be Paid, Year One $287.00K.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year One | Lessee, Operating Lease, Liability, to be Paid, Year One as first filed |
|---|---|---|
| 2026-06-30 | $357.00K 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $357.00K 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $357.00K 10-Q · filed 2026-02-17 | |
| 2025-09-30 | $287.00K 10-K · filed 2025-12-29 | |
| 2025-06-30 | $287.00K 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $287.00K 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $287.00K 10-Q · filed 2025-02-14 | |
| 2024-09-30 | $366.00K 10-K · filed 2025-01-13 | |
| 2024-06-30 | $366.00K 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $366.00K 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $366.00K 10-Q · filed 2024-02-14 | $357.00K 10-Q · filed 2023-05-12 |
| 2023-06-30 | $357.00K 10-Q · filed 2023-08-10 | |
| 2022-12-31 | $357.00K 10-Q · filed 2023-02-14 | |
| 2022-09-30 | $357.00K 10-K · filed 2023-12-21 | $348.00K 10-K · filed 2022-12-27 |
| 2022-06-30 | $348.00K 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $348.00K 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $348.00K 10-Q · filed 2022-02-11 | |
| 2021-09-30 | $309.00K 10-K · filed 2021-12-21 | |
| 2021-06-30 | $267.00K 10-Q · filed 2021-08-13 | |
| 2021-03-31 | $264.00K 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $264.00K 10-Q · filed 2021-02-12 | |
| 2020-09-30 | $241.00K 10-K · filed 2020-12-29 | |
| 2020-06-30 | $241.00K 10-Q/A · filed 2020-12-31 | |
| 2020-03-31 | $107.00K 10-Q/A · filed 2020-12-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |